James O. Armitage, MD
Professor, Internal Medicine
Division of Hematology & Oncology
University of Nebraska Medical Center
Omaha, Nebraska
Division of Hematology & Oncology
University of Nebraska Medical Center
Omaha, Nebraska
Last modified: November 26, 2018
Authored Items
Key issues concerning the treatment of patients with advanced-stage Hodgkin lymphoma
Clinical Expert Commentaries published on March 24, 2014
Benefits from Surveillance Imaging in Hodgkin Lymphoma
Clinical Expert Commentaries published on March 5, 2014
Key issues in early-stage HL
9th ISHL Highlights media published on November 4, 2013
Updates in Hodgkin Lymphoma
12th ICML Highlights in Lymphoma published on July 12, 2013
Overview of the 12th International Conference on Malignant Lymphoma
12th ICML Highlights in Lymphoma published on July 12, 2013
What are today's key treatment goals in Hodgkin lymphoma?
FAQ published on June 14, 2013
What are the risks to consider when treating a patient with Hodgkin lymphoma?
FAQ published on June 14, 2013
What is the current standard optimal chemotherapy regimen for patients with Hodgkin lymphoma?
FAQ published on June 14, 2013